During the past decade, Southwest Health Associates, P.A. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Southwest Health Associates, P.A." are "Diabetes Mellitus, Type 2" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Southwest Health Associates, P.A." in a lesser frequency.

Most popular intervention types in "Southwest Health Associates, P.A." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Exenatide extended-release" (1 trials), "LY2944876" (1 trials), "Met DR" (1 trials) and "Met IR" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Health Associates, P.A." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Health Associates, P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Southwest Health Associates, P.A., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Health Associates, P.A., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".